Quercetin acts via the G3BP1/YWHAZ axis to inhibit glycolysis and proliferation in oral squamous cell carcinoma

References

• Abbaszadeh Z, Çeşmeli S, Biray Avcı Ç. 2020. Crucial players in glycolysis: Cancer progress. Gene. 726:144158.
   PubMed Web of Science ®Google Scholar
• Akram M. 2013. Mini-review on glycolysis and cancer. J Cancer Educ. 28(3):454–457.
   PubMed Web of Science ®Google Scholar
• Cai H, Li J, Zhang Y, Liao Y, Zhu Y, Wang C, Hou J. 2019. LDHA promotes oral squamous cell carcinoma progression through facilitating glycolysis and epithelial-mesenchymal transition. Front Oncol. 9:1446.
   PubMed Web of Science ®Google Scholar
• Dos Santos Carvalho C, Fernandes MN. 2019. Effects of copper toxicity at different pH and temperatures on the in vitro enzyme activity in blood and liver of fish, Prochilodus lineatus. Mol Biol Rep. 46(5):4933–4942.
   PubMed Web of Science ®Google Scholar
• Farhadi P, Yarani R, Dokaneheifard S, Mansouri K. 2020. The emerging role of targeting cancer metabolism for cancer therapy. Tumour Biol. 42(10):1010428320965284.
   Google Scholar
• Gan Y, Ye F, He XX. 2020. The role of YWHAZ in cancer: A maze of opportunities and challenges. J Cancer. 11(8):2252–2264.
   PubMed Web of Science ®Google Scholar
• Guo H, Ding H, Tang X, Liang M, Li S, Zhang J, Cao J. 2020. Quercetin induces pro-apoptotic autophagy via SIRT1/AMPK signaling pathway in human lung cancer cell lines A549 and H1299 in vitro. Thorac Cancer. 12(9):1415–1422.
   Web of Science ®Google Scholar
• Hu X, Xia K, Xiong H, Su T. 2021. G3BP1 may serve as a potential biomarker of proliferation, apoptosis, and prognosis in oral squamous cell carcinoma. J Oral Pathol Med. 50(10):995–1004.
   PubMed Web of Science ®Google Scholar
• Huang CY, Chan CY, Chou IT, Lien CH, Hung HC, Lee MF. 2013. Quercetin induces growth arrest through activation of FOXO1 transcription factor in EGFR-overexpressing oral cancer cells. J Nutr Biochem. 24(9):1596–1603.
   PubMed Web of Science ®Google Scholar
• Jia L, Huang S, Yin X, Zan Y, Guo Y, Han L. 2018. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction. Life Sci. 208:123–130.
   PubMed Web of Science ®Google Scholar
• Li LJ, Li GW, Xie Y. 2019. Regulatory effects of glabridin and quercetin on energy metabolism of breast cancer cells. Zhongguo Zhong Yao Za Zhi. 44(17):3786–3791.
   PubMedGoogle Scholar
• Li Y, Wang J, Zhong S, Li J, Du W. 2020. Overexpression of G3BP1 facilitates the progression of colon cancer by activating beta-catenin signaling. Mol Med Rep. 22(5):4403–4411.
   PubMed Web of Science ®Google Scholar
• Mao L, Wu X, Gong Z, Yu M, Huang Z. 2021. PDIA6 contributes to aerobic glycolysis and cancer progression in oral squamous cell carcinoma. World J Surg Oncol. 19(1):88.
   PubMed Web of Science ®Google Scholar
• Min L, Ruan Y, Shen Z, Jia D, Wang X, Zhao J, Sun Y, Gu J. 2015. Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients. Histopathology. 67(5):677–688.
   PubMed Web of Science ®Google Scholar
• Omer A, Barrera MC, Moran JL, Lian XJ, Di Marco S, Beausejour C, Gallouzi IE. 2020. G3BP1 controls the senescence-associated secretome and its impact on cancer progression. Nat Commun. 11(1):4979.
   PubMed Web of Science ®Google Scholar
• Shafabakhsh R, Asemi Z. 2019. Quercetin: a natural compound for ovarian cancer treatment. J Ovarian Res. 12(1):55.
   PubMedGoogle Scholar
• Shi J, Ye J, Fei H, Jiang SH, Wu ZY, Chen YP, Zhang LW, Yang XM. 2019. YWHAZ promotes ovarian cancer metastasis by modulating glycolysis. Oncol Rep. 41(2):1101–1112.
   PubMed Web of Science ®Google Scholar
• Solomon B, Young RJ, Rischin D. 2018. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments. Semin Cancer Biol. 52(Pt 2):228–240.
   PubMedGoogle Scholar
• Somasekharan SP, Zhang F, Saxena N, Huang JN, Kuo I-C, Low C, Bell R, Adomat H, Stoynov N, Foster L, et al. 2020. G3BP1-linked mRNA partitioning supports selective protein synthesis in response to oxidative stress. Nucleic Acids Res. 48(12):6855–6873.
   PubMed Web of Science ®Google Scholar
• Tu H, Ma D, Luo Y, Tang S, Li Y, Chen G, Wang L, Hou Z, Shen C, Lu H, et al. 2021. Quercetin alleviates chronic renal failure by targeting the PI3k/Akt pathway. Bioengineered. 12(1):6538–6558.
   PubMed Web of Science ®Google Scholar
• Wang J, Chen X, Tian Y, Zhu G, Qin Y, Chen X, Pi L, Wei M, Liu G, Li Z, et al. 2020. Six-gene signature for predicting survival in patients with head and neck squamous cell carcinoma. Aging (Albany NY. 12(1):767–783. )
   PubMedGoogle Scholar
• Wang Y, Fu D, Chen Y, Su J, Wang Y, Li X, Zhai W, Niu Y, Yue D, Geng H. 2018. G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas. Cell Death Dis. 9(5):501.
   PubMedGoogle Scholar
• Wang Z, Zhu X, Dong P, Cai J. 2020. Long noncoding RNA LINC00958 promotes the oral squamous cell carcinoma by sponging miR-185-5p/YWHAZ. Life Sci. 242:116782.
   PubMed Web of Science ®Google Scholar
• Wu H, Pan L, Gao C, Xu H, Li Y, Zhang L, Ma L, Meng L, Sun X, Qin H. 2019. Quercetin inhibits the proliferation of glycolysis-addicted HCC cells by reducing hexokinase 2 and Akt-mTOR pathway. Molecules. 24(10):1993.
   PubMed Web of Science ®Google Scholar
• Wu Z, Wu J, Zhao Q, Fu S, Jin J. 2020. Emerging roles of aerobic glycolysis in breast cancer. Clin Transl Oncol. 22(5):631–646.
   PubMed Web of Science ®Google Scholar
• Xiang T, Fang Y, Wang SX. 2014. Quercetin suppresses HeLa cells by blocking PI3K/Akt pathway. J Huazhong Univ Sci Technolog Med Sci. 34(5):740–744.
   PubMedGoogle Scholar
• Xiong R, Gao JL, Yin T. 2019. G3BP1 activates the TGF-beta/Smad signaling pathway to promote gastric cancer. Onco Targets Ther. 12:7149–7156.
   PubMedGoogle Scholar
• Xu WL, Liu S, Li N, Ye LF, Zha M, Li CY, Zhao Y, Pu Q, Bao JJ, Chen XJ, et al. 2021. Quercetin antagonizes glucose fluctuation induced renal injury by inhibiting aerobic glycolysis via HIF-1alpha/miR-210/ISCU/FeS pathway. Front Med (Lausanne). 8:656086.
   PubMed Web of Science ®Google Scholar
• Xu C, Wang P, Liu Y, Zhang Y, Fan W, Upton MP, Lohavanichbutr P, Houck JR, Doody DR, Futran ND, et al. 2013. Integrative genomics in combination with RNA interference identifies prognostic and functionally relevant gene targets for oral squamous cell carcinoma. PLoS Genet. 9(1):e1003169.
   PubMed Web of Science ®Google Scholar
• Yang J, Ren B, Yang G, Wang H, Chen G, You L, Zhang T, Zhao Y. 2020. The enhancement of glycolysis regulates pancreatic cancer metastasis. Cell Mol Life Sci. 77(2):305–321.
   PubMed Web of Science ®Google Scholar
• Zhang HZ, Liu JG, Wei YP, Wu C, Cao YK, Wang M. 2007. Expression of G3BP and RhoC in esophageal squamous carcinoma and their effect on prognosis. WJG. 13(30):4126–4130.
   PubMed Web of Science ®Google Scholar
• Zhang CH, Liu H, Zhao WL, Zhao WX, Zhou HM, Shao RG. 2021. G3BP1 promotes human breast cancer cell proliferation through coordinating with GSK-3beta and stabilizing beta-catenin. Acta Pharmacol Sin. 42(11):1900–1912.
   PubMed Web of Science ®Google Scholar
• Zhang LN, Zhao L, Yan XL, Huang YH. 2019. Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/beta-catenin and PI3K/AKT signaling pathways. J Cell Physiol. 234(11):20469–20484.
   PubMed Web of Science ®Google Scholar
• Zhao J, Fu X, Chen H, Min L, Sun J, Yin J, Guo J, Li H, Tang Z, Ruan Y, et al. 2021. G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer. Br J Cancer. 124(2):425–436.
   PubMed Web of Science ®Google Scholar
• Zheng H, Zhan Y, Zhang Y, Liu S, Lu J, Yang Y, Wen Q, Fan S. 2019. Elevated expression of G3BP1 associates with YB1 and p-AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection. Cancer Med. 8(16):6894–6903.
   PubMed Web of Science ®Google Scholar